−0.96USD
−16.78 MUSD
44.38 MUSD
14.07 M
About ProPhase Labs, Inc.
Sector
CEO
Ted William Karkus
Headquarters
Garden City
Website
Employees (FY)
113
Founded
1989
ISIN
US74345W1080
FIGI
BBG000F5PGF2
ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. It operates through the Diagnostic Services and Consumer Products segment. The Diagnostic Services segment includes COVID-19 and other diagnostic testing services. The Consumer Products segment consists of the manufacturing, retail customers, and personal genomics products and services. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Garden City, NY.
PRPH - Bullflag Price has broken out of a large triangle structure
Above this structure a bull formation is present which I think may be acting as a bullflag
Bars pattern placed next to price indicates my bullish bias
ProPhase Labs Announces New $6 Million Stock Repurchase PlanPRPH: ProPhase Labs, Inc.
2022-07-26 08:00:00 ProPhase Labs Announces New $6 Million Stock Repurchase Plan
$PRPH Target 11.39 for 40.97% $PRPH Target 11.39 for 40.97%
Or next add level is at 4.77
Alright... so, this chart right here is pretty SEXY!!! STRENGTH...
—
On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average.
I start every posit
Prophase buys Covid Vaccination & Testing “Passport” SolutionWith increasing news chatter around countries requiring people to have proof of Covid vaccinations before allowing travel, this headline caught my eye.
The stock has been on a bit of a downwards run, but this might be interesting enough to turn it around. Its got a pretty good support are close by
$PRPH Target 13.10 for 33.81% $PRPH Target 13.10 for 33.81%
Or next add level is at 6.48
Nice bounce.
On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average.
I am not your financial advisor. Watch my setups first before you jump in… My
PRPHSmall position swing trade. Been trading this small stuff lately and doing well. Keep it small and follow the plan. Manage risk.
Earning playCarefull here, could be a beutifull swing trade with a fantastic daytrade swing. Evaluate as it develops
Good luck
$PRPH Target 13.10 for 33.81% Or next add level is at 6.48$PRPH Target 13.10 for 33.81%
Or next add level is at 6.48
I am not your financial advisor. Watch my setups first before you jump in… My trade set ups work very well and they are for my personal reference and if you decide to trade them you do so at your own risk. I will gladly answer questions
$PRPH Prophase Lads Targets ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer consumer healthcare products and dietary supplements. Its products include TK supplement. The company was founded by Guy J. Quigley and Charles A. Phillips in July 19
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PRPH is 6.27 USD — it has decreased by 14.69% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ProPhase Labs, Inc. stocks are traded under the ticker PRPH.
ProPhase Labs, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
PRPH stock is 23.45% volatile and has beta coefficient of −0.22. Check out the list of the most volatile stocks — is ProPhase Labs, Inc. there?
One year price forecast for ProPhase Labs, Inc. has a max estimate of 11.00 USD and a min estimate of 11.00 USD.
PRPH earnings for the last quarter are −0.30 USD whereas the estimation was −0.20 USD which accounts for −53.85% surprise. Estimated earnings for the next quarter are −0.26 USD. See more details about ProPhase Labs, Inc. earnings.
ProPhase Labs, Inc. revenue for the last quarter amounts to 8.37 M USD despite the estimated figure of 13.06 M USD. In the next quarter revenue is expected to reach 10.71 M USD.
Yes, you can track ProPhase Labs, Inc. financials in yearly and quarterly reports right on TradingView.
PRPH stock has risen by 3.81% compared to the previous week, the month change is a 28.22% rise, over the last year ProPhase Labs, Inc. has showed a 20.73% decrease.
PRPH net income for the last quarter is −8.75 M USD, while the quarter before that showed −5.14 M USD of net income which accounts for −70.22% change. Track more ProPhase Labs, Inc. financial stats to get the full picture.
Today ProPhase Labs, Inc. has the market capitalization of 113.14 M, it has decreased by 4.21% over the last week.
Like other stocks, PRPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ProPhase Labs, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 113.00 employees. See our rating of the largest employees — is ProPhase Labs, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ProPhase Labs, Inc. technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ProPhase Labs, Inc. stock shows the buy signal. See more of ProPhase Labs, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ProPhase Labs, Inc. future price: according to them, PRPH price has a max estimate of 11.00 USD and a min estimate of 11.00 USD. Read a more detailed ProPhase Labs, Inc. forecast: see what analysts think of ProPhase Labs, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ProPhase Labs, Inc. EBITDA is −14.92 M USD, and current EBITDA margin is −33.60%. See more stats in ProPhase Labs, Inc. financial statements.